Record first half, momentum building
The recent interims confirmed that Covid-19 was minimally disruptive operationally in H1 20 and,...
Read moreGrowth in a tough market, share price headroom
The most pleasing aspect of Tatton’s trading update for the six months ending 30 Sep 2020 (H1 2021)...
Read more
Graft progress reflected in new valuation
RUA Life Sciences has announced that their graft products have moved into the final long-term...
Read moreBrisk sales growth sustained
Brisk retail sales growth, an accelerated online performance and new store openings were key...
Read more
Valuation increased on AUM inflow momentum
A step-change in client inflows is what Impax’s FY20 should be remembered for. The global...
Read moreThrough the eye of the Covid storm
‘What doesn’t kill you makes you stronger’. Ditto for radiation detection expert Kromek, which was...
Read moreFurther progress & strong cash generation
Quality firms often use a crisis as a catalyst to streamline operations and improve services: not...
Read moreProving the doubters wrong
Northbridge’s results for 6 months to June were most encouraging, with revenues falling just 4.5%...
Read moreRegister to be first
Get research on the companies that interest you straight to your inbox
